Cancer/testis antigen 2
Cancer/testis antigen 2 (ORF2 (1-11)) is a synthetic peptide fragment derived from a well-characterized cancer/testis antigen, a protein family notable for its restricted expression in normal adult tissues but prevalent presence in various malignancies. As a short, defined peptide sequence corresponding to the N-terminal region of the ORF2 protein, it serves as a valuable molecular tool for the study of tumor-associated antigens and their immunological properties. Its precise sequence and structural fidelity make it particularly suited for applications in immunological research, peptide mapping, and the development of analytical assays exploring antigen-specific responses. The use of this peptide enables researchers to dissect the biochemical and cellular mechanisms underlying antigen recognition, T cell activation, and immune surveillance in cancer biology.
Epitope mapping: The defined sequence of this peptide allows for detailed mapping of immunogenic epitopes within the cancer/testis antigen family. By exposing immune cells or antibodies to the peptide, researchers can identify specific regions responsible for immune recognition, thereby elucidating the minimal antigenic determinants required for T cell or antibody binding. This approach supports the rational design of peptide-based immunological assays and contributes to a deeper understanding of antigen structure-function relationships.
Immunological assay development: As a representative fragment of a tumor-associated antigen, the peptide can be incorporated into ELISA, ELISPOT, or flow cytometry-based assays to evaluate antigen-specific cellular or humoral immune responses. Its use enables the quantification and characterization of T cell or antibody reactivity in preclinical research, aiding in the assessment of immune recognition patterns and the validation of candidate biomarkers for immune monitoring studies.
Peptide-based vaccine research: The synthetic peptide is frequently utilized in the exploration of peptide-based immunogens for experimental oncology and basic immunology studies. By serving as a model antigen, it helps researchers investigate the parameters that influence antigen processing, presentation, and T cell activation. Such studies are instrumental in guiding the design of next-generation peptide constructs for immunological research, including the optimization of adjuvant systems and delivery platforms.
T cell receptor specificity studies: The peptide offers a controlled substrate for evaluating T cell receptor (TCR) recognition and cross-reactivity. By presenting the sequence in vitro, investigators can analyze TCR binding affinities, specificity profiles, and the molecular mechanisms governing T cell activation. These insights are crucial for understanding immune escape, tolerance, and the development of antigen-specific T cell reagents for research use.
Antibody characterization and validation: The defined structure of the peptide allows it to serve as a reference antigen for the generation and validation of monoclonal or polyclonal antibodies. Researchers can employ it in binding assays to assess antibody specificity, affinity, and cross-reactivity, which is essential for the development of reliable immunodetection reagents. Such validation supports the broader application of antibody-based tools in cancer biology and immunodiagnostic research.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More